[1]Patent:US2014/256775,2014,A1,.Locationinpatent:Paragraph0178;0183;0184
[2]JournalofMedicinalChemistry,2009,vol.52,#9,p.2776-2785
[3]BulletindelaSocieteChimiquedeFrance,1910,vol.<4>7,p.219
[4]JournaloftheChemicalSociety,1901,vol.79,p.1192
[5]BioorganicChemistry,1998,vol.26,#3,p.157-168
[6]Patent:WO2017/9651,2017,A1,.Locationinpatent:Page/Pagecolumn86;87
[1]JournaloftheAmericanChemicalSociety,1948,vol.70,p.304
[2]BulletindelaSocieteChimiquedeFrance,1929,vol.<4>45,p.841
[1]Patent:US2014/256775,2014,A1,
[1]Patent:US2014/256775,2014,A1,
[1]BulletindelaSocieteChimiquedeFrance,1910,vol.<4>7,p.219
[1]BulletindelaSocieteChimiquedeFrance,1910,vol.<4>7,p.219
[1]Patent:US2014/256775,2014,A1.Locationinpatent:Paragraph0178;0183;0184
[2]JournalofMedicinalChemistry,2009,vol.52,p.2776-2785
[3]Patent:US2019/241504,2019,A1.Locationinpatent:Paragraph0105;0108-0109
[4]BulletindelaSocieteChimiquedeFrance,1910,vol.<4>7,p.219
[5]JournaloftheChemicalSociety,1901,vol.79,p.1192
[6]BioorganicChemistry,1998,vol.26,p.157-168
[7]Patent:WO2017/9651,2017,A1.Locationinpatent:Page/Pagecolumn86;87
[1]BulletinoftheAcademyofSciencesoftheUSSRDivisionofChemicalScience,1965,p.348-349 IzvestiyaAkademiiNaukSSSR,SeriyaKhimicheskaya,1965,p.369-370
[1]JournalofMedicinalChemistry,1989,vol.32,p.2214-2221
Title: Khan S, et al. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 Dec;25(12):1938-1947.